These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
388 related items for PubMed ID: 2909548
1. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease. Noh J, Hamada N, Saito H, Oyanagi H, Ishikawa N, Momotani N, Ito K, Morii H. J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548 [Abstract] [Full Text] [Related]
2. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease. Ochi Y, Hamazu M, Kajita Y, Nagata A. Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054 [Abstract] [Full Text] [Related]
3. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T. Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951 [Abstract] [Full Text] [Related]
5. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients. Chung YJ, Lee BW, Kim JY, Jung JH, Min YK, Lee MS, Lee MK, Kim KW, Chung JH. Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435 [Abstract] [Full Text] [Related]
6. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells. Kishihara M, Nakao Y, Baba Y, Kobayashi N, Matsukura S, Kuma K, Fujita T. J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672 [Abstract] [Full Text] [Related]
9. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients. Hill BL, Erlanger BF. Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350 [Abstract] [Full Text] [Related]
10. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects. Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y, Yoshimura H, Ito K. J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248 [Abstract] [Full Text] [Related]
11. Differences between thyrotropin receptor antibody bioactivity and inhibition of 125I-bovine thyrotropin binding. Wallaschofski H, Kaczmarek M, Miehle K, Hentschel B, Paschke R. Thyroid; 2000 Oct; 10(10):897-907. PubMed ID: 11081256 [Abstract] [Full Text] [Related]
13. Clinical significance of anti-TSH antibody in sera from patients with Graves' disease and other thyroid disorders. Akamizu T, Mori T, Imura H, Noh J, Hamada N, Ito K, Koizumi Y, Yamada T, Fujihira T, Eto S. J Endocrinol Invest; 1989 Oct; 12(7):483-8. PubMed ID: 2571629 [Abstract] [Full Text] [Related]
18. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K. J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336 [Abstract] [Full Text] [Related]
19. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease. Tamaki H, Amino N, Iwatani Y, Tachi J, Kimura M, Mitsuda N, Ichihara K, Tanizawa O, Miyai K. Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017 [Abstract] [Full Text] [Related]
20. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody. Ochi Y, Kajita Y, Hamazu M, Nagata A. Horm Res; 2003 May; 59(5):222-8. PubMed ID: 12714785 [Abstract] [Full Text] [Related] Page: [Next] [New Search]